Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Autor: Murillo Perez, Fiorella, Hirschfield, GM, Corpechot, C, Floreani, A, Mayo, MJ, van der Meer, Adriaan, Ponsioen, CY, Lammers, Wim, Pares, A, Invernizzi, P, Carbone, M, Battezzati, PM, Nevens, F, Kowdley, KV, Thorburn, D, Mason, AL, Trivedi, PJ, Lindor, KD, Bruns, T, Dalekos, GN, Gatselis, NK, Verhelst, X, Janssen, HL, Hansen, BE, Gulamhusein, A, Grp, GPS

Publikováno v: Alimentary pharmacology & therapeutics, 50(10), 1127-1136. Wiley-Blackwell
Alimentary Pharmacology & Therapeutics, 50(10), 1127-1136. Wiley-Blackwell Publishing Ltd

Background: Fibrosis stage predicts prognosis in patients with chronic liver disease independent of aetiology, although its precise role in risk stratification in patients with primary biliary cholangitis (PBC) remains undefined. Aim: To assess the u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7deceeb55299ef0c27edb6465c2b3e33
https://pubmed.ncbi.nlm.nih.gov/31850576